Type 1 Diabetes Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults between 18 and 65 years of age (inclusive)
• People with type 1 diabetes who have been using intensive insulin therapy — either multiple daily injections or an insulin pump (with or without a continuous glucose monitor that automatically adjusts insulin doses) — for at least 3 months
• People who choose to take part willingly and sign a written consent form

Who may not be able to join:

• People who have certain skin conditions or skin changes at the area where the glucose sensor would be placed, including severe psoriasis, recent burns or severe sunburn, severe eczema, severe scarring, large tattoos, dermatitis herpetiformis, severe rash, or a Staphylococcus aureus (staph) skin infection
• People who have had an allergic skin reaction to medical adhesives (the sticky part of medical patches or devices)
• People with a history of frequent abscesses (painful infected lumps) at insulin pump catheter sites
• People who have had a severe low blood sugar episode in the 3 months before screening — defined as losing consciousness or having a seizure that required emergency medical treatment
• People who cannot feel or recognise the warning signs of low blood sugar (a condition called hypoglycemia unawareness)
• People with conditions that make low blood sugar more likely, such as untreated or poorly managed thyroid or adrenal disease
• People who have had diabetic ketoacidosis (a serious diabetes complication) in the 3 months before screening
• People with a history of epilepsy or fainting episodes in the 6 months before screening
• People with unstable blood vessel or heart conditions — including stroke, mini-stroke (TIA), heart disease, poor circulation in the legs, or serious irregular heartbeat — where symptoms have occurred or worsened in the last 6 months, or where treatment is not adequate
• People with anaemia (low haemoglobin / low red blood cell levels)
• People who are scheduled to have an X-ray, MRI, CT scan, or diathermy (a heat-based medical treatment) during the study period
• Women who are pregnant, breastfeeding, planning to become pregnant, or not willing to use an adequate method of contraception during the study
• People who are currently in another clinical study, have been in one within the 2 weeks before screening, or plan to join another study that the trial doctor believes could affect safety or results
• People who are unwilling to avoid eating certain foods (listed in a study document called Appendix 3) beyond the amounts allowed in the study
• People with cognitive difficulties (problems with thinking, memory, or understanding), or anyone the trial doctor considers unsuitable or at increased risk from taking part
• People who wear a pacemaker or similar implanted medical device
• People whose HbA1c (a measure of average blood sugar over roughly 3 months) is above 9.5%
• People who have a close personal or professional relationship with the study sponsor or the trial doctor that could create a conflict of interest
• People who are unwilling or unable to follow the study procedures as required

Important: Always verify eligibility with the trial site directly before applying.